Virpax plans three trials based on platform drug delivery systems in 2024

Preclinical work is currently underway for all three candidates, with the first two trials set to start by mid-2024.

Jul 11, 2023 - 20:00

Virpax plans three trials based on platform drug delivery systems in 2024

Preclinical work is currently underway for all three candidates, with the first two trials set to start by mid-2024.

Read the original article

Tags:

Previous Article

STAT+: How the political right came to back psychedelics to treat trauma

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Listen: Lilly’s obesity drug, the power of radiation, &...

Nov 9, 2023

What a review of gender-affirming care research by a top pediatrics group actually means

What a review of gender-affirming care research by a to...

Aug 25, 2023

CBC acquires UCB’s neurology and allergy business in China

CBC acquires UCB’s neurology and allergy business in China

Dec 3, 2024